169 related articles for article (PubMed ID: 28283598)
21. Contrast-enhanced fat-suppressed FLAIR for the characterization of leptomeningeal inflammation in optic neuritis.
Pino-Lopez L; Wenz H; Böhme J; Maros M; Schlichtenbrede F; Groden C; Förster A
Mult Scler; 2019 May; 25(6):792-800. PubMed ID: 29683029
[TBL] [Abstract][Full Text] [Related]
22. Cortical involvement and leptomeningeal inflammation in myelin oligodendrocyte glycoprotein antibody disease: A three-dimensional fluid-attenuated inversion recovery MRI study.
Tzanetakos D; Tzartos JS; Vakrakou AG; Breza M; Velonakis G; Stathopoulos P; Pantou E; Markakis I; Papadimitriou D; Karavasilis E; Toulas P; Evangelopoulos ΜE; Koutsis G; Anagnostouli M; Stefanis L; Kilidireas C
Mult Scler; 2022 Apr; 28(5):718-729. PubMed ID: 34410179
[TBL] [Abstract][Full Text] [Related]
23. Use of Magnetic Resonance Imaging to Visualize Leptomeningeal Inflammation in Patients With Multiple Sclerosis: A Review.
Zurawski J; Lassmann H; Bakshi R
JAMA Neurol; 2017 Jan; 74(1):100-109. PubMed ID: 27893883
[TBL] [Abstract][Full Text] [Related]
24. Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies.
Maggi P; Absinta M; Grammatico M; Vuolo L; Emmi G; Carlucci G; Spagni G; Barilaro A; Repice AM; Emmi L; Prisco D; Martinelli V; Scotti R; Sadeghi N; Perrotta G; Sati P; Dachy B; Reich DS; Filippi M; Massacesi L
Ann Neurol; 2018 Feb; 83(2):283-294. PubMed ID: 29328521
[TBL] [Abstract][Full Text] [Related]
25. Imaging spinal cord atrophy in progressive myelopathies: HTLV-I-associated neurological disease (HAM/TSP) and multiple sclerosis (MS).
Azodi S; Nair G; Enose-Akahata Y; Charlip E; Vellucci A; Cortese I; Dwyer J; Billioux BJ; Thomas C; Ohayon J; Reich DS; Jacobson S
Ann Neurol; 2017 Nov; 82(5):719-728. PubMed ID: 29024167
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and Prediction of Relapses in Susac Syndrome: A New Use for MR Postcontrast FLAIR Leptomeningeal Enhancement.
Coulette S; Lecler A; Saragoussi E; Zuber K; Savatovsky J; Deschamps R; Gout O; Sabben C; Aboab J; Affortit A; Charbonneau F; Obadia M
AJNR Am J Neuroradiol; 2019 Jul; 40(7):1184-1190. PubMed ID: 31248864
[TBL] [Abstract][Full Text] [Related]
27. Leptomeningeal Enhancement Is Associated with Transient Neurologic Deficits after Flow Diversion of Intracranial Aneurysms.
Li Y; Funk C; Dawkins D; Simpson D; Yu JJ; Boly M; Ahmed A
World Neurosurg; 2018 Dec; 120():e94-e99. PubMed ID: 30121409
[TBL] [Abstract][Full Text] [Related]
28. A pilot trial of ocrelizumab for modulation of meningeal enhancement in multiple sclerosis.
Dahal S; Allette YM; Naunton K; Harrison DM
Mult Scler Relat Disord; 2024 Jan; 81():105344. PubMed ID: 38035495
[TBL] [Abstract][Full Text] [Related]
29. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
[TBL] [Abstract][Full Text] [Related]
30. Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis.
Hildesheim FE; Ramasamy DP; Bergsland N; Jakimovski D; Dwyer MG; Hojnacki D; Lizarraga AA; Kolb C; Eckert S; Weinstock-Guttman B; Zivadinov R
Mult Scler Relat Disord; 2021 Jan; 47():102653. PubMed ID: 33333417
[TBL] [Abstract][Full Text] [Related]
31. Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging study.
Guttmann CR; Rousset M; Roch JA; Hannoun S; Durand-Dubief F; Belaroussi B; Cavallari M; Rabilloud M; Sappey-Marinier D; Vukusic S; Cotton F
Mult Scler; 2016 May; 22(6):761-9. PubMed ID: 26362901
[TBL] [Abstract][Full Text] [Related]
32. CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients.
Joseph FG; Hirst CL; Pickersgill TP; Ben-Shlomo Y; Robertson NP; Scolding NJ
J Neurol Neurosurg Psychiatry; 2009 Mar; 80(3):292-6. PubMed ID: 18829628
[TBL] [Abstract][Full Text] [Related]
33. T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.
Thaler C; Faizy T; Sedlacik J; Holst B; Stellmann JP; Young KL; Heesen C; Fiehler J; Siemonsen S
PLoS One; 2015; 10(12):e0144693. PubMed ID: 26659852
[TBL] [Abstract][Full Text] [Related]
34. Brain: gadolinium-enhanced fast fluid-attenuated inversion-recovery MR imaging.
Mathews VP; Caldemeyer KS; Lowe MJ; Greenspan SL; Weber DM; Ulmer JL
Radiology; 1999 Apr; 211(1):257-63. PubMed ID: 10189481
[TBL] [Abstract][Full Text] [Related]
35. Susac's syndrome: Leptomeningeal enhancement on 3D FLAIR MRI.
Engisch R; Titelbaum DS; Chilver-Stainer L; Kellner-Weldon F
Mult Scler; 2016 Jun; 22(7):972-4. PubMed ID: 27207452
[TBL] [Abstract][Full Text] [Related]
36. Canine meningeal disease: associations between magnetic resonance imaging signs and histologic findings.
Keenihan EK; Summers BA; David FH; Lamb CR
Vet Radiol Ultrasound; 2013; 54(5):504-15. PubMed ID: 23721347
[TBL] [Abstract][Full Text] [Related]
37. Leptomeningeal enhancement on post-contrast FLAIR images for early diagnosis of Susac syndrome.
Bellanger G; Biotti D; Adam G; Darcourt J; Roques M; Patsoura S; Savatovsky J; Obadia M; Menjot de Champfleur N; Charif M; Labauge P; Cotton F; Durand Dubief F; Tourdias T; Dulau C; Kremer S; De Sèze J; Ciron J; Varenne F; Viguier A; Lerebours F; Larrue V; Cognard C; Bonneville F
Mult Scler; 2022 Feb; 28(2):189-197. PubMed ID: 33988466
[TBL] [Abstract][Full Text] [Related]
38. Leptomeningeal enhancement in multiple sclerosis: a focus on patients treated with hematopoietic stem cell transplantation.
Marchi L; Mariottini A; Viti V; Bianchi A; Nozzoli C; Repice AM; Boncompagni R; Ginestroni A; Damato V; Barilaro A; Chiti S; Saccardi R; Fainardi E; Massacesi L
Front Neurol; 2024; 15():1373385. PubMed ID: 38899059
[TBL] [Abstract][Full Text] [Related]
39. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex.
Resnick L; diMarzo-Veronese F; Schüpbach J; Tourtellotte WW; Ho DD; Müller F; Shapshak P; Vogt M; Groopman JE; Markham PD
N Engl J Med; 1985 Dec; 313(24):1498-504. PubMed ID: 2999592
[TBL] [Abstract][Full Text] [Related]
40. Punctate pattern: A promising imaging marker for the diagnosis of natalizumab-associated PML.
Hodel J; Darchis C; Outteryck O; Verclytte S; Deramecourt V; Lacour A; Zins M; Pruvo JP; Vermersch P; Leclerc X
Neurology; 2016 Apr; 86(16):1516-23. PubMed ID: 27009257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
